GreyBrook logotype
Investor Login Contact Us

Changing the Lives of More than 20,000 Patients, 2021 Was A Year of Continued Growth for Greenbrook TMS

December 31, 2021

Greenbrook TMS (NASDAQ: GBNH, TSX: GTMS) is a leading provider of TMS therapy, an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder and other mental health disorders founded by Greybrook and firm’s CEO, Bill Leonard, with 149 centres across the U.S. The company has provided nearly 1,000,000 treatments changing the lives of more than 20,000 patients and has achieved phenomenal growth over the past year through clinic acquisitions, and expansions into new therapies and treatment methods.

Greenbrook TMS was founded with the belief that mental health care as it then existed was failing too many people. Only 49% of patients respond to their first-round antidepressant medication. The other 51% endured lengthy cycles of medication trial-and-error with little improvement, often experiencing side effects like weight gain and sexual dysfunction which worsened their depression symptoms. We knew there had to be a better way.

In 2011, Greenbrook TMS opened its first location in Tysons Corner, Virginia, with a vision to bring together the best care teams and technology into a more personalized, more accessible, and most importantly more effective treatment experience.

Today, more than 10 years after launching that first centre, Greenbrook has provided nearly 1,000,000 treatments and changed the lives of more than 20,000 patients. “We have the largest clinical data set in the U.S., and our TMS patients experience a 62% response rate which is well above the current antidepressant medication therapy rates and that is for patients who have already failed other treatments”, explained Bill Leonard, CEO Greenbrook TMS. “Many of our patients achieve full remission from their depression symptoms—all with little to no side effects”.  With more than 40% growth since 2015, Greenbrook’s 149 centers span 17 states; each location offers state-of-the-art treatment technology in a soothing, spa-like environment, bringing the Greenbrook care experience to more communities. In early 2021, to complement Greenbrook’s deep expertise in depression treatment, the company piloted offering Spravato, a nasal esketamine spray that is FDA-approved for treatment resistant major depressive disorder.

“Our passion has always been fueled by the goal of changing patient’s lives for the better. Looking ahead, as the pandemic continues to disrupt all aspects of daily life, rates of depression continue to soar and the importance of and need for our work is greater than ever. To help meet treatment needs in the community, and building on our successes in 2021, we will expand our Spravato offering to 23 locations by the end of Q1 2022”.

“We are very proud of what the Greenbrook team has accomplished and their commitment to helping so many people. As we expand Greenbrook’s clinical footprint, we are excited to see the impact that TMS and other innovative therapies can have on the lives of patients struggling with mental health”, Elias Vamvakas, Chairman Greenbrook TMS and Chairman Greybrook Capital.

To learn more about Greenbrook TMS, visit


Latest Insights

Miami Becomes First City in the U.S. to Achieve the WELL Health-Safety Rating and Advocates Others Do the Same

June 24, 2022

This forward-thinking accomplishment cements Miami and Mayor Francis X. Suarez’s commitment to supporting healthy buildings in cities. Mayor Suarez recently leveraged his leadership role as President of the U.S. Conference of Mayors to encourage fellow mayors to join him in…

Greybrook Participates in the 2022 Land & Development Conference

June 20, 2022

Returning to an in person format this year, the much-anticipated event focused on real-time trends and opportunities impacting owners, developers, investors, and lenders by bringing together industry leaders and active participants to provide market insights on development, acquisition, current challenges,…

Construction Advances at Society Wynwood

Portfolio Updates
June 16, 2022

We are pleased to report that construction of Society Wynwood’s thoughtfully designed multi-family residence has progressed significantly since our last update with all three crane towers now erected, the building’s foundation poured and vertical construction progressed to the second of…

McMichael Estates Sold Out and Construction Underway

Portfolio Updates
June 14, 2022

The strong sales momentum allowed for an accelerated start to construction and 65 of 75 homes are currently being built. With construction well underway, home closings are set to commence in Fall 2022 and continue through Q4 2023. Located at…

Greybrook Hosts Canadian Business Thought Leadership Panel

June 3, 2022

Listen to the full panel below. Live from the ROM’s C5 Lounge and moderated by our Greybrook Securities’ CEO, Sasha Cucuz, the event featured a dynamic panel comprised of business leaders Jon Love C.M., Founder & CEO, KingSett Capital, Sabrina…

What’s Driving Construction Costs & How Are Rising Rates Impacting the Housing Market?

June 1, 2022

In our inaugural episode we shared our views on how the macro and micro variables at the time were impacting the economy, the housing market, and our views on new acquisitions and the management of our existing portfolio. Since our…

Greybrook and PMG Announce Groundbreaking of Society Atlanta

Portfolio Updates
May 31, 2022

Greybrook alongside developer partner, PMG are pleased to announce the groundbreaking of Society Atlanta, a 31-storey multi-family development located at 811 Peachtree St. Designed by national architecture firm Cooper Carry, the mixed-use property is the first of PMG’s Society Living…

CEO Peter Politis Featured Speaker at Leaders Lounge 2022

May 19, 2022

This highly anticipated industry networking event brought together a notable group of prominent Canadian real estate leaders, including our very own CEO, Peter Politis, who joined fellow industry players, including our developer partners, Benjamin Bakst, CEO and Co-Founder, Marlin Spring,…

Greybrook Realty Partners Invests $26,385,000 in a Low-Rise Residential Development Project with Treasure Hill in Brooklin, Ontario

Portfolio Updates
May 17, 2022

Greybrook Realty Partners Inc. announced today the successful closing of an equity investment by its managed issuer of $26,385,000 to acquire and oversee the development of a prime parcel of land located in Brooklin, Ontario. Together with its developer partner,…

Greybrook Realty Partners Invests $25,300,000 in a High-Rise Residential Development Project with Metropia in Toronto, Ontario 

Portfolio Updates
May 16, 2022

Greybrook Realty Partners Inc. announced today the successful closing of an equity investment by its managed issuer of $25,300,000 to acquire and oversee the development of an assembly of properties located on the south side of Dundas Street East between…

[geot_filter exclude_country="cn"]All Publications[/geot_filter][geot_filter country="cn"]所有出版物[/geot_filter]

Join our newsletter and keep up to date with our news & insights

Contact us